Verrica Pharmaceuticals Inc. (VRCA) Dividend History

Verrica Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing dermatology solutions. The company's lead products target FDA-approved indications for the treatment of skin conditions caused by viruses, such as molluscum contagiosum and common warts. Verrica aims to address unmet medical needs with innovative and well-tolerated therapies for dermatological issues.

10 North High Street, West Chester, PA, 19380
Phone: 484-453-3300
Website: https://www.verrica.com

Dividend History

Verrica Pharmaceuticals Inc. currently does not pay dividends

Company News

Verrica Pharmaceuticals Announces Acceptance of Two Abstracts Featuring Positive Preliminary Topline Results of VP-315 for the Treatment of Basal Cell Carcinoma at the 2024 Fall Clinical Dermatology Conference

Verrica Pharmaceuticals announced the acceptance of two abstracts featuring positive preliminary results from a Phase 2 study of its investigational therapy VP-315 for the treatment of basal cell carcinoma. The data showed promising safety, tolerability, and antitumor efficacy.

GlobeNewswire Inc.
Planet Fitness To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Roth MKM cut the price target for Roblox Corporation (NYSE:RBLX) from $55 to $35. Roth MKM analyst Eric Handler downgraded the stock from Buy to Neutral. Roblox shares fell 1.6% to close at $30.96 on Monday. See how other analysts view this stock. Needham boosted the price target for Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) from $8 to $16. Needham analyst Serge Belanger maintained a Buy rating. Verrica Pharmaceuticals shares jumped 19.5% to close at $9.56 on Monday. See how other analysts view this stock. Baird cut Fortrea Holdings Inc. (NASDAQ:FTRE) price target from $45 to $36. Baird analyst Eric Coldwell upgraded the stock from Neutral to Outperform. Fortrea ...Full story available on Benzinga.com

Benzinga

Featured Companies: AGYS AIR FTRE NTRA PLNT RBLX SAM
Verrica Pharmaceuticals Inc. (VRCA) Reports Q1 Loss, Tops Revenue Estimates

Verrica Pharmaceuticals (VRCA) delivered earnings and revenue surprises of 29.63% and 41.97%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research

Featured Companies: COSM
Why Shares of Verrica Pharmaceuticals Are Plummeting on Monday

The company's shares dropped because it will require financing to help launch its first marketed product.

The Motley Fool
Hot Penny Stocks to Buy Now? 3 to Watch in Early July

Check these penny stocks out for your watchlist The post Hot Penny Stocks to Buy Now? 3 to Watch in Early July appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

PennyStocks

Featured Companies: AKBA

Page data last updated 07/22/2025 15:49:09 UTC